Top

Published in:

01-09-2005 | Original Article

Impaired expression of hepatic multidrug resistance protein 2 is associated with posthepatectomy hyperbilirubinemia in patients with biliary cancer

Authors: Tatsuharu Yamada, Toshiyuki Arai, Masato Nagino, Koji Oda, Junichi Shoda, Hiroshi Suzuki, Yuichi Sugiyama, Yuji Nimura

Published in: Langenbeck's Archives of Surgery | Issue 5/2005

Abstract

Background and aims

Hyperbilirubinemia is a critical complication following hepatectomy for biliary cancer. Hepatic multidrug resistance protein 2 (MRP2), a bilirubin transporter, is shown to be down-regulated by acute biliary obstruction in rats. However, little is known about the effect of chronic obstruction by malignancy on the MRP2 expression in patients or the association of MRP2 expression with posthepatectomy hyperbilirubinemia.

Materials and Methods

The MRP2 expression before hepatectomy was determined by immunostaining and Western blotting in patients with biliary cancer. To directly determine the effect of chronic bile duct obstruction on the MRP2 expression, the expression levels were compared between the cholestatic and noncholestatic lobes in each of seven patients. In another 39 patients, the correlation of the MRP2 expression of the anticipated remnant liver with the posthepatectomy severe hyperbilirubinemia, defined as a serum total bilirubin concentration≥200 μmol/l, was evaluated.

Results

The MRP2 staining in the cholestatic lobes was weak and not restricted to the canalicular membrane, unlike the noncholestatic lobes. The expression levels in the cholestatic lobes were 45% of those in the noncholestatic lobes. Postoperative maximum bilirubin levels were significantly correlated with MRP2 expression of the anticipated remnant liver. The MRP2 expression had been already impaired before hepatectomy in all patients who eventually developed severe hyperbilirubinemia.

Conclusions

Decreased MRP2 expression, caused by biliary obstruction due to cancer, is a possible risk factor for posthepatectomy severe hyperbilirubinemia.

Nimura Y, Hayakawa N, Kamiya J, Kondo S, Shionoya S (1990) Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J Surg 14:535–544CrossRefPubMed

Nagino M, Nimura Y, Hayakawa N, Kamiya J, Kondo S, Sasaki R, Hamajima N (1993) Logistic regression and discriminant analyses of hepatic failure after liver resection for carcinoma of the biliary tract. World J Surg 17:250–255CrossRefPubMed

Pichlmayr R, Weimann A, Klempnauer J, Oldhafer KJ, Maschek H, Tusch G, Ringe B (1996) Surgical treatment in proximal bile duct cancer. A single-center experience. Ann Surg 224:628–638

Miyazaki M, Ito H, Nakagawa K, Ambiru S, Shimizu H, Shimizu Y, Kato A, Nakamura S, Omoto H, Nakajima N, Kimura F, Suwa T (1998) Aggressive surgical approaches to hilar cholangiocarcinoma: hepatic or local resection? Surgery 123:131–136CrossRefPubMed

Neuhaus P, Jonas S, Bechstein WO, Lohmann R, Radke C, Kling N, Wex C, Lobeck H, Hintze R (1999) Extended resections for hilar cholangiocarcinoma. Ann Surg 230:808–819

Kosuge T, Yamamoto J, Shimada K, Yamasaki S, Makuuchi M (1999) Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg 230:663–671

Tsao JI, Nimura Y, Kamiya J, Hayakawa N, Kondo S, Nagino M, Miyachi M, Kanai M, Uesaka K, Oda K, Rossi RL, Braasch JW, Dugan JM (2000) Management of hilar cholangiocarcinoma. Comparison of an American and a Japanese experience. Ann Surg 232:166–174

Nagino M, Kamiya J, Uesaka K, Sano T, Yamamoto H, Hayakawa N, Kanai M, Nimura Y (2001) Complications of hepatectomy for hilar cholangiocarcinoma. World J Surg 25:1277–1283CrossRefPubMed

Arai T, Yoshikai Y, Kamiya J, Nagino M, Uesaka K, Yuasa N, Oda K, Sano T, Nimura Y (2001) Bilirubin impairs bactericidal activity of neutrophils through an antioxidant mechanism in vitro. J Surg Res 96:107–113CrossRefPubMed

10.

Dixon JM, Armstrong CP, Duffy SW, Davies GC (1983) Factors affecting morbidity and mortality after surgery for obstructive jaundice: a review of 373 patients. Gut 24:845–852PubMed

11.

Welsh FKS, Ramsden CW, MacLennan K, Sheridan MB, Barclay GR, Guillou PJ, Reynolds JV (1998) Increased intestinal permeability and altered mucosal immunity in cholestatic jaundice. Ann Surg 227:205–212

12.

Trauner M, Meier PJ, Boyer JL (1997) Molecular pathogenesis of cholestasis. N Engl J Med 339:1217–1227CrossRef

13.

Trauner M, Meier PJ, Boyer JL (1999) Molecular regulation of hepatocellular transport systems in cholestasis. J Hepatol 31:165–178CrossRefPubMed

14.

Trauner M, Arrese M, Soroka CJ, Ananthanarayanan M, Koeppel TA, Schlosser SF, Suchy FJ, Keppler D (1997) The rat canalicular conjugates export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology 113:255–264PubMed

15.

Vos TA, Hooiveld GJEJ, Konning H, Childs S, Meijer DKF, Moshage H, Jansen PLM, Muller M (1998) Up-regulation of the multidrug resistance genes, mrp1 and mdr1b, and down-regulation of the organic anion transporter, mrp2, and the bile salt transporter, spgp, in endotoxemic rat liver. Hepatology 28:1637–1644CrossRefPubMed

16.

Kubitz R, Wettstein M, Warskulat U, Haussinger D (1999) Regulation of the multidrug resistance protein 2 in the rat liver by lipopolysaccharide and dexamethasone. Gastroenterology 116:401–410PubMed

17.

Paulusma CC, Kothe MJC, Bakker CTM, Bosma PJ, Bokhoven I, Marle J, Bolder U, Tytgat GNJ, Elferink RPJ (2000) Zonal down-regulation and redistribution of the multidrug resistance protein 2 during bile duct ligation in rat liver. Hepatology 31:684–693CrossRefPubMed

18.

Nagino M, Nimura Y, Kamiya J et al (1995) Changes in hepatic lobe volume in biliary tract cancer patients after right portal vein embolization. Hepatology 21:434–439PubMed

19.

Uesaka K, Nimura Y, Nagino M (1996) Changes in hepatic lobar function after right portal embolization. An appraisal by biliary indocyanine green excretion. Ann Surg 223:77–83

20.

Taniguchi K, Wada M, Kohno K, Nakamura T, Kawabe T, Kawakami M, Kagotani K, Okumura K, Akiyama S, Kuwano M (1996) A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Res 56:4124–4129PubMed

21.

Shoda J, Kano M, Oda K, Kamiya J, Nimura Y, Suzuki H, Sugiyama Y, Miyazaki H, Todoroki T, Stengelin S, Kramer W, Matsuzaki Y, Tanaka N (2001) The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory function. Am J Gastroenterol 96:3368–3378CrossRefPubMed

22.

Shoda J, Miura T, Utsunomiya H, Oda K, Yamamoto M, Kano M, Ikegami T, Tanaka N, Akita H, Ito K, Suzuki H, Sugiyama Y (2004) Genipin enhances Mrp2 (Abcc2)-mediated bile formation and organic anion transport in rat liver. Hepatology 39:167–178CrossRefPubMed

23.

Shimizu T, Sato O, Tsukada K (1996) Reestimation of the bilirubin decrease rate “b” (b value) in patients with obstructive jaundice. J Hepatobiliary Pancreat Surg 3:12–16CrossRef

24.

Sano K, Kubota K, Bandai Y, Makuuci M (1999) Rate of bilirubin decrease as a risk predictor in hepato-biliary–pancreatic surgery. Hepatogastroenterology 46:2171–2177PubMed

25.

Boerma EJ (1990) Research into the results of resection of hilar bile duct cancer. Surgery 108:572–580PubMed

26.

Sugiura Y, Nakamura S, Iida S, Hosoda Y, Ikeuchi S, Mori S, Sugioka A (1994) Extensive resection of the bile ducts combined with liver resection for cancer of the main hepatic duct junction: a cooperative study of the Keio Bile Duct Cancer Study Group. Surgery 115:445–451PubMed

27.

Klempnauer J, Ridder GJ, von Wasielewski R, Werner M, Weimann A, Pichlmayr R (1997) Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors. J Clin Oncol 15:947–954PubMed

28.

Nagino M, Nimura Y, Kamiya J, Kanai M, Uesaka K, Hayakawa N, Yamamoto H, Kondo S, Nishio H (1998) Segmental liver resections for hilar cholangiocarcinoma. Hepatogastroenterology 45:7–13PubMed

29.

Lee JM, Trauner M, Soroka CJ, Stieger B (2000) Expression of the bile salt export pump is maintained after chronic cholestasis in the rat. Gastroenterology 118:163–172PubMed

30.

Soroka CJ, Lee JM, Azzaroli F, Boyer JL (2001) Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver. Hepatology 33:783–791CrossRefPubMed

31.

Zollner G, Fickert P, Zenz R, Fuchsbichler A, Stumptner C, Kenner L, Ferenci P, Stauber RE, Krejs GJ, Denk H, Zatloukal K, Trauner M (2001) Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases. Hepatology 33:633–646CrossRefPubMed

32.

Kawaguchi T, Sakisaka S, Mitsuyama K, Harada M, Koga H, Taniguchi E, Sasatomi K, Kimura R, Ueno T, Sawada N, Mori M, Sata M (2000) Cholestasis with altered structure and function of hepatocyte tight junction and decreased expression of canalicular multispecific organ anion transporter in a rat model of colitis. Hepatology 31:1285–1295CrossRefPubMed

33.

Nagino M, Hayakawa N, Nimura Y, Dohke M, Kitagawa S (1992) Percutaneous transhepatic biliary drainage in patients with malignant biliary obstruction of the hepatic confluence. Hepatogastroenterology 39:296–300PubMed

34.

Nimura Y, Kamiya J, Kondo S, Nagino M, Kanai M (1995) Technique of inserting multiple biliary drains and management. Hepatogastroenterology 42:323–331PubMed

35.

Kanai M, Nimura Y, Kamiya J, Kondo S, Nagino M, Miyachi M, Goto Y (1996) Preoperative intrahepatic segmental cholangitis in patients with advanced carcinoma involving the hepatic hilus. Surgery 119:498–504PubMed

Title: Impaired expression of hepatic multidrug resistance protein 2 is associated with posthepatectomy hyperbilirubinemia in patients with biliary cancer
Authors: Tatsuharu Yamada
Toshiyuki Arai
Masato Nagino
Koji Oda
Junichi Shoda
Hiroshi Suzuki
Yuichi Sugiyama
Yuji Nimura
Publication date: 01-09-2005
Publisher: Springer-Verlag
Published in: Langenbeck's Archives of Surgery / Issue 5/2005
Print ISSN: 1435-2443
Electronic ISSN: 1435-2451
DOI: https://doi.org/10.1007/s00423-005-0564-5

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Impaired expression of hepatic multidrug resistance protein 2 is associated with posthepatectomy hyperbilirubinemia in patients with biliary cancer

Abstract

Background and aims

Materials and Methods

Results

Conclusions

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background and aims

Materials and Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 5/2005

Detection and clinical implications of minimal residual disease in gastro-intestinal cancer

Primary incisional hernia repair with or without polypropylene mesh: a report on 384 patients with 5-year follow-up

Modified radical lymphadenectomy (D1.5) for T2–3 gastric cancer

Pylorus-preserving gastrectomy in gastric cancer surgery—open and laparoscopic approaches

Sentinel node metastasectomy in thin ≤1-mm melanoma

9th Annual Meeting on Surgical Research / 9. Chirurgische Forschungstage 2005, 19-21 September 2005, Frankfurt am Main, Germany